We are now exploring the applications of the NVIDIA Clara healthcare application framework. Built to support cross-disciplinary workflows, NVIDIA Clara Discovery
combines the power of accelerated computing, AI, and machine learning to supercharge the entire drug development process, unlocking the potential to bring life-saving drugs to market faster. Clara Discovery is a collection of frameworks, applications, and AI models enabling GPU-accelerated drug discovery, with support for research in genomics, proteomics, microscopy, virtual screening, computational chemistry, visualization, clinical imaging, and natural language processing (NLP). Browse these tools in NGC, NVIDIA's hub for GPU-optimized software.
We are very happy to be presenting our approach to generative chemistry and the Chemistry42 platform at NVIDIA GTC21
(registration is free) and the application of this platform which enabled the nomination of a preclinical candidate for a novel target for idiopathic pulmonary fibrosis (IPF) in under 18 months.
Drug discovery is a very lengthy and risky process. Here is a video
describing the process and our recent novel drug discovery milestone.